Sanofi is pressing ahead with plans to dramatically reshape its Consumer Healthcare portfolio by divesting a basket of 16 brands to Germany’s Stada. The transaction is expected to close in the third quarter of 2021, subject to approval of relevant regulatory authorities and other customary closing conditions.
Through the deal, Stada will acquire for an undisclosed sum the registrations, trademarks and related commercial rights to the 16 brands which are marketed across Europe, with the majority of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?